adenosine monophosphate has been researched along with albuterol in 26 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 8 (30.77) | 18.2507 |
2000's | 15 (57.69) | 29.6817 |
2010's | 3 (11.54) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Finnerty, JP; Holgate, ST; Phillips, GD | 1 |
Bolliger, CT; Elsasser, S; Joos, L; Perruchoud, AP; Solèr, M | 1 |
Douma, RR; Koëter, GH; Postma, DS; Weersink, EJ | 1 |
Lipworth, BJ; McFarlane, LC; Tan, KS | 1 |
Barnes, PJ; Worsdell, M; Yates, DH | 1 |
Aikman, SL; Barnes, PJ; Harris, JG; Jensen, MW; O'Connor, BJ; Taylor, DA | 1 |
Cockcroft, DW | 1 |
Cowan, J; Flannery, E; McLachlan, C; Ramsay, CM; Taylor, DR | 1 |
Dempsey, OJ; Lipworth, BJ; Mistry, C; Sims, EJ; Wilson, AM | 1 |
Arshad, H; Harrison, JE; Holgate, ST; Stryszak, P | 1 |
Cockcroft, DW; Davis, BE; Jokic, R; Swystun, VA | 1 |
Dempsey, OJ; Lipworth, BJ; Sims, EJ; Wilson, AM | 1 |
Gutiérrez, V; Marín, J; Prieto, L; Torres, V; Uixera, S | 1 |
Cervera, A; Gutiérrez, V; Liñana, J; Prieto, L | 1 |
Bates, CE; Currie, GP; Haggart, K; Lee, DK; Lipworth, BJ | 1 |
Bates, CE; Currie, GP; Jackson, CM; Lee, DK; Lipworth, BJ | 1 |
Barnes, PJ; Cambridge, LM; Catley, MC; Giembycz, MA; Lum, H; Meja, KK; Newton, R | 1 |
Fang, X; Frank, JA; Matthay, MA; McAuley, DF | 1 |
Guarino, F; Polosa, R; Prosperini, G; Russo, C; Spicuzza, L; Zeng, D | 1 |
Fardon, TC; Hodge, MR; Lee, DK; Lipworth, BJ | 1 |
Badiola, C; Bruno, L; Ferrer, A; Gutiérrez, V; Lanuza, A; Pérez-Francés, C; Prieto, L | 1 |
Amirav, I; Luder, AS; Yacobov, R | 1 |
Barberà, JA; Gómez, FP; Manrique, HA; Muñoz, PA; Peña, AM; Roca, J; Rodríguez-Roisin, R | 1 |
Aalbers, R; Boorsma, M; Jonkers, RE; van der Woude, HJ | 1 |
Burns, P; Lipworth, BJ; Nair, A; Short, P | 1 |
Austin, RP; Bonnert, R; Cadogan, E; Connolly, S; Gardiner, P; Jordan, S; Lawson, M; Nicholls, DJ; Paine, SW; Young, A | 1 |
1 review(s) available for adenosine monophosphate and albuterol
Article | Year |
---|---|
Inhaled beta2-agonists and airway responses to allergen.
Topics: Adenosine Monophosphate; Administration, Inhalation; Adrenergic beta-Agonists; Albuterol; Allergens; Asthma; Bronchoconstriction; Bronchodilator Agents; Cross-Over Studies; Double-Blind Method; Drug Tolerance; Forced Expiratory Volume; Humans; Methacholine Chloride; Randomized Controlled Trials as Topic; Salmeterol Xinafoate; Terbutaline; Time Factors | 1998 |
19 trial(s) available for adenosine monophosphate and albuterol
Article | Year |
---|---|
Comparative protective effect of the inhaled beta 2-agonist salbutamol (albuterol) on bronchoconstriction provoked by histamine, methacholine, and adenosine 5'-monophosphate in asthma.
Topics: Adenosine Monophosphate; Administration, Inhalation; Adolescent; Adult; Aerosols; Albuterol; Asthma; Bronchial Spasm; Dose-Response Relationship, Drug; Double-Blind Method; Female; Forced Expiratory Volume; Histamine; Humans; Male; Methacholine Chloride; Methacholine Compounds; Middle Aged | 1990 |
Bronchoprotection by salmeterol: cell stabilization or functional antagonism? Comparative effects on histamine- and AMP-induced bronchoconstriction.
Topics: Adenosine Monophosphate; Adult; Albuterol; Asthma; Bronchi; Bronchial Provocation Tests; Bronchoconstriction; Bronchodilator Agents; Cross-Over Studies; Double-Blind Method; Female; Forced Expiratory Volume; Histamine; Humans; Male; Muscle, Smooth; Salmeterol Xinafoate; Time Factors | 1994 |
Fluticasone propionate, salmeterol xinafoate, and their combination in the treatment of nocturnal asthma.
Topics: Adenosine Monophosphate; Administration, Inhalation; Administration, Topical; Adrenergic beta-Agonists; Adult; Albuterol; Androstadienes; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Bronchial Hyperreactivity; Bronchial Provocation Tests; Bronchoconstrictor Agents; Circadian Rhythm; Double-Blind Method; Drug Therapy, Combination; Female; Fluticasone; Glucocorticoids; Humans; Male; Methacholine Chloride; Salmeterol Xinafoate | 1997 |
Effect of regular salmeterol treatment on albuterol-induced bronchoprotection in mild asthma.
Topics: Adenosine Monophosphate; Adrenergic beta-Agonists; Adult; Albuterol; Asthma; Bronchial Hyperreactivity; Bronchial Provocation Tests; Bronchoconstrictor Agents; Bronchodilator Agents; Cross-Over Studies; Double-Blind Method; Drug Interactions; Female; Forced Expiratory Volume; Humans; Male; Methacholine Chloride; Middle Aged; Salmeterol Xinafoate | 1997 |
Comparison of salmeterol and albuterol-induced bronchoprotection against adenosine monophosphate and histamine in mild asthma.
Topics: Adenosine Monophosphate; Adrenergic beta-Agonists; Adult; Albuterol; Asthma; Bronchial Provocation Tests; Bronchoconstriction; Bronchodilator Agents; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Forced Expiratory Volume; Histamine; Humans; Male; Salmeterol Xinafoate | 1997 |
Bronchoprotective and bronchodilator effects of single doses of (S)-salbutamol, (R)-salbutamol and racemic salbutamol in patients with bronchial asthma.
Topics: Adenosine Monophosphate; Adult; Albuterol; Asthma; Bronchi; Bronchodilator Agents; Cross-Over Studies; Double-Blind Method; Drug Hypersensitivity; Female; Forced Expiratory Volume; Humans; Male; Methacholine Chloride; Middle Aged; Spirometry; Stereoisomerism; Time Factors | 1999 |
Additive bronchoprotective and bronchodilator effects with single doses of salmeterol and montelukast in asthmatic patients receiving inhaled corticosteroids.
Topics: Acetates; Adenosine Monophosphate; Administration, Inhalation; Administration, Oral; Adrenergic beta-Agonists; Albuterol; Asthma; Bronchial Hyperreactivity; Bronchial Provocation Tests; Cross-Over Studies; Cyclopropanes; Drug Therapy, Combination; Glucocorticoids; Humans; Leukotriene Antagonists; Quinolines; Respiratory Function Tests; Salmeterol Xinafoate; Single-Blind Method; Sulfides; Treatment Outcome | 2000 |
Mometasone furoate antagonizes AMP-induced bronchoconstriction in patients with mild asthma.
Topics: Adenosine Monophosphate; Administration, Inhalation; Albuterol; Anti-Inflammatory Agents; Asthma; Bronchoconstriction; Bronchodilator Agents; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Forced Expiratory Volume; Humans; Mometasone Furoate; Peak Expiratory Flow Rate; Pregnadienediols | 2000 |
Regular inhaled salbutamol : effect on airway responsiveness to methacholine and adenosine 5'-monophosphate and tolerance to bronchoprotection.
Topics: Adenosine Monophosphate; Administration, Inhalation; Adrenergic beta-Agonists; Adult; Albuterol; Asthma; Bronchi; Bronchial Hyperreactivity; Bronchial Provocation Tests; Bronchoconstrictor Agents; Cross-Over Studies; Double-Blind Method; Humans; Methacholine Chloride | 2001 |
Evaluation of salmeterol or montelukast as second-line therapy for asthma not controlled with inhaled corticosteroids.
Topics: Acetates; Adenosine Monophosphate; Administration, Inhalation; Administration, Topical; Adrenergic beta-Agonists; Adult; Albuterol; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Breath Tests; Bronchial Provocation Tests; Bronchodilator Agents; Cross-Over Studies; Cyclopropanes; Eosinophils; Female; Glucocorticoids; Humans; Leukocyte Count; Leukotriene Antagonists; Male; Nitric Oxide; Peak Expiratory Flow Rate; Quinolines; Respiratory Mechanics; Salmeterol Xinafoate; Single-Blind Method; Steroids; Sulfides | 2001 |
Effect of salmeterol on seasonal changes in airway responsiveness and exhaled nitric oxide in pollen-sensitive asthmatic subjects.
Topics: Adenosine Monophosphate; Administration, Inhalation; Adolescent; Adult; Airway Resistance; Albuterol; Asthma; Breath Tests; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Nitric Oxide; Rhinitis, Allergic, Seasonal; Salmeterol Xinafoate; Seasons | 2002 |
Effects of montelukast on surrogate inflammatory markers in corticosteroid-treated patients with asthma.
Topics: Acetates; Adenosine Monophosphate; Adolescent; Adult; Aged; Albuterol; Androstadienes; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Biomarkers; Bronchial Provocation Tests; Cross-Over Studies; Cyclopropanes; Double-Blind Method; Drug Therapy, Combination; Female; Fluticasone; Forced Expiratory Volume; Humans; Leukotriene Antagonists; Male; Middle Aged; Quinolines; Salmeterol Xinafoate; Severity of Illness Index; Sulfides; Treatment Outcome | 2003 |
Effects of fluticasone plus salmeterol versus twice the dose of fluticasone in asthmatic patients.
Topics: Adenosine Monophosphate; Adult; Albuterol; Androstadienes; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Bronchodilator Agents; Cross-Over Studies; Drug Therapy, Combination; Endpoint Determination; Fluticasone; Humans; Respiratory Function Tests; Salmeterol Xinafoate; Single-Blind Method | 2003 |
Effect of salbutamol on nasal symptoms and mast cell degranulation induced by adenosine 5' monophosphate nasal challenge.
Topics: Adenosine Monophosphate; Adolescent; Adrenergic beta-Agonists; Adult; Albuterol; Anti-Inflammatory Agents; Cell Degranulation; Cross-Over Studies; Depression, Chemical; Double-Blind Method; Female; Histamine; Humans; Male; Mast Cells; Nasal Lavage Fluid; Nasal Provocation Tests; Rhinitis, Allergic, Seasonal; Serine Endopeptidases; Sneezing; Tryptases | 2005 |
Addition of fexofenadine to inhaled corticosteroid therapy to reduce inflammatory biomarkers in atopic asthma.
Topics: Adenosine Monophosphate; Administration, Inhalation; Adolescent; Adrenal Cortex Hormones; Adult; Albuterol; Androstadienes; Anti-Allergic Agents; Asthma; Biomarkers; Bronchial Provocation Tests; Drug Therapy, Combination; Eosinophil Cationic Protein; Eosinophils; Female; Fluticasone; Humans; Hypersensitivity, Immediate; Inflammation; Male; Nitric Oxide; Respiratory Function Tests; Salmeterol Xinafoate; Terfenadine; Treatment Outcome | 2005 |
Effect of fluticasone propionate-salmeterol therapy on seasonal changes in airway responsiveness and exhaled nitric oxide levels in patients with pollen-induced asthma.
Topics: Adenosine Monophosphate; Adolescent; Adult; Aged; Airway Resistance; Albuterol; Androstadienes; Asthma; Bronchial Provocation Tests; Bronchodilator Agents; Drug Combinations; Female; Fluticasone; Fluticasone-Salmeterol Drug Combination; Forced Expiratory Volume; Humans; Male; Middle Aged; Nitric Oxide; Seasons; Sulfonamides; Treatment Outcome | 2005 |
Formoterol turbuhaler is as effective as salbutamol diskus in relieving adenosine-induced bronchoconstriction in children.
Topics: Adenosine Monophosphate; Administration, Inhalation; Adolescent; Adrenergic beta-Agonists; Albuterol; Asthma; Bronchial Provocation Tests; Bronchoconstriction; Bronchoconstrictor Agents; Bronchodilator Agents; Child; Dose-Response Relationship, Drug; Ethanolamines; Female; Forced Expiratory Volume; Formoterol Fumarate; Humans; Inhalation; Male; Nebulizers and Vaporizers; Placebos; Recovery of Function; Spirometry; Time Factors | 2007 |
Protective effect of budesonide/formoterol compared with formoterol, salbutamol and placebo on repeated provocations with inhaled AMP in patients with asthma: a randomised, double-blind, cross-over study.
Topics: Adenosine Monophosphate; Administration, Inhalation; Adrenergic beta-Agonists; Adult; Albuterol; Asthma; Bronchial Provocation Tests; Bronchoconstriction; Bronchoconstrictor Agents; Bronchodilator Agents; Budesonide; Cross-Over Studies; Double-Blind Method; Drug Combinations; Ethanolamines; Female; Forced Expiratory Volume; Formoterol Fumarate; Glucocorticoids; Humans; Male; Maximal Midexpiratory Flow Rate; Middle Aged; Netherlands; Time Factors; Treatment Outcome; Young Adult | 2010 |
Effects of intranasal salmeterol and fluticasone given alone and in combination in persistent allergic rhinitis.
Topics: Adenosine Monophosphate; Administration, Intranasal; Adrenergic beta-2 Receptor Agonists; Adult; Albuterol; Androstadienes; Anti-Allergic Agents; Cross-Over Studies; Double-Blind Method; Drug Combinations; Female; Fluticasone; Fluticasone-Salmeterol Drug Combination; Glucocorticoids; Humans; Male; Rhinitis, Allergic, Perennial; Salmeterol Xinafoate; Treatment Outcome | 2012 |
6 other study(ies) available for adenosine monophosphate and albuterol
Article | Year |
---|---|
Loss of normal cyclical beta 2 adrenoceptor regulation and increased premenstrual responsiveness to adenosine monophosphate in stable female asthmatic patients.
Topics: Adenosine Monophosphate; Adolescent; Adrenergic beta-Agonists; Adult; Albuterol; Analysis of Variance; Asthma; Estradiol; Female; Follicular Phase; Forced Expiratory Volume; Humans; Luteal Phase; Peak Expiratory Flow Rate; Progesterone; Receptors, Adrenergic, beta-2 | 1997 |
Airway obstruction induced by inhaled acetaldehyde in asthma: repeatability relationship to adenosine 5'-monophosphate responsiveness.
Topics: Acetaldehyde; Adenosine Monophosphate; Administration, Inhalation; Adolescent; Adult; Airway Obstruction; Albuterol; Asthma; Blood Pressure; Bronchial Provocation Tests; Bronchoconstriction; Bronchoconstrictor Agents; Bronchodilator Agents; Dose-Response Relationship, Drug; Female; Forced Expiratory Volume; Humans; Male; Methacholine Chloride; Middle Aged; Reproducibility of Results; Statistics as Topic | 2002 |
Adenovirus-mediated delivery and expression of a cAMP-dependent protein kinase inhibitor gene to BEAS-2B epithelial cells abolishes the anti-inflammatory effects of rolipram, salbutamol, and prostaglandin E2: a comparison with H-89.
Topics: Activating Transcription Factor 1; Adaptor Proteins, Signal Transducing; Adenosine Monophosphate; Adenoviridae; Albuterol; Animals; Arachidonic Acid; Carrier Proteins; Cells, Cultured; Cyclic AMP Response Element-Binding Protein; Cyclic AMP-Dependent Protein Kinases; Dinoprostone; DNA-Binding Proteins; Drug Interactions; Epithelial Cells; Gene Expression Regulation; Gene Transfer Techniques; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Intracellular Signaling Peptides and Proteins; Isoquinolines; Phosphorylation; Rabbits; Rolipram; Sulfonamides; Transcription Factors; Tritium | 2004 |
Clinically relevant concentrations of beta2-adrenergic agonists stimulate maximal cyclic adenosine monophosphate-dependent airspace fluid clearance and decrease pulmonary edema in experimental acid-induced lung injury.
Topics: Adenosine Monophosphate; Adrenergic beta-Agonists; Albuterol; Animals; Extravascular Lung Water; Pulmonary Alveoli; Pulmonary Edema; Pulmonary Gas Exchange; Rats; Rats, Sprague-Dawley; Respiratory Distress Syndrome; Salmeterol Xinafoate; Stereoisomerism | 2004 |
Adenosine 5'-monophosphate in asthma: gas exchange and sputum cellular responses.
Topics: Adenosine Monophosphate; Adrenergic beta-Agonists; Adult; Albuterol; Asthma; Bronchial Provocation Tests; Bronchoconstriction; Bronchoconstrictor Agents; Cohort Studies; Female; Forced Expiratory Volume; Humans; Hypoxia; Male; Methacholine Chloride; Pulmonary Gas Exchange; Sputum | 2008 |
Characteristics of AZD9708, a novel, selective β2-adrenoceptor agonist with rapid onset and long duration of action.
Topics: Adenosine Monophosphate; Adrenergic beta-2 Receptor Agonists; Albuterol; Animals; Asthma; Benzothiazoles; beta-Alanine; Blood Proteins; Bronchi; Bronchodilator Agents; Ethanolamines; Formoterol Fumarate; Guinea Pigs; Humans; Male; Muscle Relaxation; Protein Binding; Pulmonary Disease, Chronic Obstructive; Receptors, Adrenergic, beta-2; Salmeterol Xinafoate; Time Factors | 2012 |